bromfenac has been researched along with Diabetes Mellitus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Babazono, T; Endo, N; Hirose, A; Kitano, S; Ogihara, R; Takeda, R; Tobimatsu, Y | 1 |
| Elbarawy, AA; Gabr, AF; Kamel, MF | 1 |
| Amon, M; Findl, O; Goslings, WRO; Güell, JL; Henry, YP; Joosse, MV; Kohnen, T; Murta, JCN; Nuijts, RMMA; Rulo, AHF; Schouten, JSAG; Tassignon, MJ; van den Biggelaar, FJHM; Veldhuizen, CA; Wielders, LHP; Winkens, B | 1 |
3 trial(s) available for bromfenac and Diabetes Mellitus
| Article | Year |
|---|---|
Comparison of the Effect of Bromfenac versus Betamethasone Ophthalmic Solutions in Patients with Diabetic Macular Edema.
Topics: Aged; Betamethasone; Diabetes Mellitus; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Middle Aged; Ophthalmic Solutions; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome | 2023 |
Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema.
Topics: Angiogenesis Inhibitors; Diabetes Mellitus; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Ranibizumab; Tomography, Optical Coherence; Treatment Outcome | 2023 |
European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract Extraction; Dexamethasone; Diabetes Mellitus; Female; Glucocorticoids; Humans; Macular Edema; Male; Ophthalmic Solutions; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2018 |